Paper41664047
Long-term functional and clinical outcomes of intraarticular double-cross-linked high molecular weight hyaluronic acid (Crespine Gel Plus) injection in knee osteoarthritis: a one year prospective study.
Suppan VKL and 6 others. BMC Musculoskelet Disord, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Long-term functional and clinical outcomes of intraarticular double-cross-linked high molecular weight hyaluronic acid (Crespine Gel Plus) injection in knee osteoarthritis: a one year prospective study. Papers, record 41664047. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41664047
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Long-term functional and clinical outcomes of intraarticular double-cross-linked high molecular weight hyaluronic acid (Crespine Gel Plus) injection in knee osteoarthritis: a one year prospective study.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hyaluronic Acid | Major topic |
| Osteoarthritis, Knee | Major topic |
| Viscosupplements | Major topic |
| Humans | |
| Prospective Studies | |
| Female | |
| Male | |
| Injections, Intra-Articular | |
| Aged | |
| Treatment Outcome | |
| Middle Aged | |
| Gels | |
| Pain Measurement | |
| Molecular Weight | |
| Time Factors |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT07736781 | Research Title: Long Term Functional Outcome of a Single Hyaluronic Acid Injection in Improving Symptoms and Function in Patients With Knee Osteoarthritis - A Single-Arm Open-Label Study (DIART ONE). | Background |
Source ClinicalTrials.gov
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38504099 | Association of long-term use of non-steroidal anti-inflammatory drugs with knee osteoarthritis: a prospective multi-cohort study over 4-to-5 years. | Sci Rep | 2024 | https://conductscience.org/library/papers/38504099 | PubMed |
| 2 | 26488691 | A Randomized, Controlled Trial of Total Knee Replacement. | N Engl J Med | 2015 | https://conductscience.org/library/papers/26488691 | PubMed |
| 3 | 40101939 | Treatment of knee osteoarthritis with a single injection of autologous micro-fragmented adipose tissue is not superior to a placebo saline injection: a blinded randomised controlled trial with 2-year follow-up. | Br J Sports Med | 2025 | https://conductscience.org/library/papers/40101939 | PubMed |
| 4 | 27629533 | Synovial fluid adipokines are associated with clinical severity in knee osteoarthritis: a cross-sectional study in female patients with joint effusion. | Arthritis Res Ther | 2016 | https://conductscience.org/library/papers/27629533 | PubMed |
| 5 | 25857826 | Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis--an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks. | BMC Med | 2015 | https://conductscience.org/library/papers/25857826 | PubMed |
| 6 | 30072113 | Why we should definitely include intra-articular hyaluronic acid as a therapeutic option in the management of knee osteoarthritis: Results of an extensive critical literature review. | Semin Arthritis Rheum | 2019 | https://conductscience.org/library/papers/30072113 | PubMed |
| 7 | 30647185 | The OMERACT-OARSI Core Domain Set for Measurement in Clinical Trials of Hip and/or Knee Osteoarthritis. | J Rheumatol | 2019 | https://conductscience.org/library/papers/30647185 | PubMed |
| 8 | 29155833 | Do intra-articular hyaluronic acid injections delay total knee replacement in patients with osteoarthritis - A Cox model analysis. | PLoS One | 2017 | https://conductscience.org/library/papers/29155833 | PubMed |
| 9 | 38610715 | A Cross-Sectional Study of Factors Predicting the Duration of the Efficacy of Viscosupplementation in Knee Osteoarthritis. | J Clin Med | 2024 | https://conductscience.org/library/papers/38610715 | PubMed |
| 10 | 37838308 | 30 years with the Knee injury and Osteoarthritis Outcome Score (KOOS). | Osteoarthritis Cartilage | 2024 | https://conductscience.org/library/papers/37838308 | PubMed |
| 11 | 32722615 | Knee Osteoarthritis: A Review of Pathogenesis and State-Of-The-Art Non-Operative Therapeutic Considerations. | Genes (Basel) | 2020 | https://conductscience.org/library/papers/32722615 | PubMed |
| 12 | 35383651 | AAOS Clinical Practice Guideline Summary: Management of Osteoarthritis of the Knee (Nonarthroplasty), Third Edition. | J Am Acad Orthop Surg | 2022 | https://conductscience.org/library/papers/35383651 | PubMed |
| 13 | 35887749 | Time to Total Knee Arthroplasty after Intra-Articular Hyaluronic Acid or Platelet-Rich Plasma Injections: A Systematic Literature Review and Meta-Analysis. | J Clin Med | 2022 | https://conductscience.org/library/papers/35887749 | PubMed |
| 14 | 14613558 | The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis. | Health Qual Life Outcomes | 2003 | https://conductscience.org/library/papers/14613558 | PubMed |
| 15 | 32893726 | Decrease in opioid and intra-articular corticosteroid burden after intra-articular hyaluronic acid for knee osteoarthritis treatment. | Pain Manag | 2020 | https://conductscience.org/library/papers/32893726 | PubMed |
| 16 | 26578719 | Product Differences in Intra-articular Hyaluronic Acids for Osteoarthritis of the Knee. | Am J Sports Med | 2016 | https://conductscience.org/library/papers/26578719 | PubMed |
| 17 | 28215182 | Pain relief that matters to patients: systematic review of empirical studies assessing the minimum clinically important difference in acute pain. | BMC Med | 2017 | https://conductscience.org/library/papers/28215182 | PubMed |
| 18 | 38212040 | EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update. | Ann Rheum Dis | 2024 | https://conductscience.org/library/papers/38212040 | PubMed |
| 19 | 20699161 | The contribution of osteoarthritis to functional limitations and disability. | Clin Geriatr Med | 2010 | https://conductscience.org/library/papers/20699161 | PubMed |
| 20 | 33814937 | Delay to TKA and Costs Associated with Knee Osteoarthritis Care Using Intra-Articular Hyaluronic Acid: Analysis of an Administrative Database. | Clin Med Insights Arthritis Musculoskelet Disord | 2021 | https://conductscience.org/library/papers/33814937 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41664047
GET https://conductscience.org/api/papers/v1/41664047/references?page=2